The "Corneal Edema - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering.A comprehensive report has been released providing valuable insights into the diagnosis, ...
ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...
Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25If approved, FILSPARI ...
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced it received regulatory approval to ...
Daily Independent on MSN9h
Dikko, Itemuagbor Seek Ways To Develop Nigerian SportsDikko (left) with ItemuagborChairman, National Sports Commission, Mallam Shehu Dikko has met with foremost sports marketer and CEO Pamodzi Sports Marketing Ltd. Chief Mike Itemuagbor, on how to ...
Daily Independent on MSN10h
Saka To Return In Arsenal’s Champs League Last 16Saka in action during the match…Ben White Expected This Saturday Against Leicester (WITH AGENCY REPORTS) – Arsenal forward, Bukayo Saka, is expected back in the Gunners Round of 16 Champions League ...
Bayer seeks European approval of extended 6-month treatment interval for Eylea 8 mg to treat nAMD & diabetic macular edema: Berlin Tuesday, February 11, 2025, 10:00 Hrs [IST] Baye ...
Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback